Gilead pays $4.3B for CymaBay, the biotech that never gave up on liver disease med

0

12.02.2024 16:59

Fiercebiotech.com

Gilead pays $4.3B for CymaBay, the biotech that never gave up on liver disease med aarmstrong Mon, 02/12/2024 - 08:59

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *